title: [What's new in rectal cancer?].
abstract: BACKGROUND
  In recent years, multidisciplinary therapeutic management of rectal cancer has evolved. This progress had interest radio and chemotherapy.
  
  
  OBJECTIVE
  To describe the main spots of the progress in the therapeutic strategies of the disease, surgical techniques and standardization of these techniques, particularly regarding locoregional extension in the mesorectum.
  
  
  METHODS
  Literature review.
  
  
  RESULTS
  Treatment of rectal cancer is multidisciplinary. On the surgical field, excision of the mesorectum (total mesorectal excision [TME]) has reduced local recurrence and the genitourinary sequelae. Meanwhile, chemoradiotherapy has become important. The standard now is to indicate to T3 T4 N+ tumors to decrease local recurrence without improving survival, however.
  
  
  CONCLUSIONS
  Advances in the management of rectal cancer with both imaging progress and therapeutic modalities have improved the prognosis and survival of this cancer.
authors: Sadreddine
authors: S
authors: Ben Abid
authors: Rania
authors: R
authors: Hefaiedh
authors: Zeineb
authors: Z
authors: Mzoughi
authors: Nizar
authors: N
authors: Miloudi
authors: Arfaa
authors: A
authors: Naafa
authors: Med Tahar
authors: MT
authors: Khalfallah
mesh_terms: D059248:Chemoradiotherapy / Q000639:trends; D003952:Diagnostic Imaging / Q000379:methods / Q000639:trends*; D013505:Digestive System Surgical Procedures / Q000639:trends; D006801:Humans; D017410:Practice Guidelines as Topic; D012004:Rectal Neoplasms / Q000175:diagnosis / Q000628:therapy*; D035703:Therapies, Investigational / Q000379:methods / Q000639:trends*